Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Merck's Keytruda hits the skids in pivotal trial, putting its liver cancer nod at risk

fiercepharmaFebruary 21, 2019

Tag: Keytruda , Merck , immunotherapy

PharmaSources Customer Service